About Difinity
Our focus is to leverage the power of technology in two fields: medical devices and medical technologies. We work to develop various solutions in those fields to innovate and improve the lives of our users and patients. Our team is composed of medical, engineering, regulatory, and technology professionals. Our goal is to improve patient care delivery while pushing forward disruptive technologies in medical care.
We are currently in the process of engineering and developing the following technologies to bring to market:
A novel platform automatic injection device developed to increase safety, speed, and ease of use in emergency medical situations using pods - the first modular and interchangeable autoinjector of its kind.
Patents granted in key jurisdictions
Prototype developed
Testing Underway
A medical device designed to improve hypodermic medication delivery systems with a safer and more robust needle. NeedSafe is the safest needle protective and delivery device to be ever developed.
Patent issued/pending in various jurisdictions
Prototype under development
Our Team
David Kim, MD, FRCPC, MSc, DAvMed
CEODavid is a recipient of the BC Community Achievement Award for his work in leadership, philanthropy, and process optimization. He joins Difinity with significant experience in leading and executing within the charitable sector as the founder and director of various non-profit organizations. David is a physician specializing in Emergency Medicine with subspecialty training in Aerospace Medicine and holds a MSc in Aerospace Medicine from King's College London.
Damien Tak, BSc, CPL
CTODamien has a Bachelor of Science with Distinction from UBC and has most recently worked as a public servant for the Government of Canada. He has worked in leading and founding roles with a number charities and organizations and is always looking to solve problems. Damien wants to empower those around him and has a passion to change the world on a macro scale.
Larry Murphy, BSc, RAC-US, ISO Lead Auditor
Chief Regulatory OfficerLarry has an extensive work history in both pharmaceutical and medical device companies across the spectrum of Clinical Affairs, Regulatory Affairs, Quality Assurance and Quality Control. Larry has held senior leadership positions at several successful Canadian biotech companies. He has experience working with regulatory bodies including Health Canada, FDA and European authorities. Larry has a BSc Biochemistry from the University of Victoria. Larry has a certified ISO 13485 lead auditor and holds a Regulatory Affairs Certification (US).
Adrianna Rowe, MD, FRCPC
PharmacotherapeuticsAdrianna is an emergency physician at University Health Network's Toronto Western and Toronto General hospitals. She has an interest in clinical pharmacology and toxicology, and is currently completing a fellowship in clinical pharmacology and toxicology at the University of Toronto. She aspires to apply her expertise to improve patient care through helping Difinity in improving drug administration and prevention of adverse drug events.
Trevor Skutezky, MD, FRCPC, MBA, BASc
Business DevelopmentTrevor is a physician specializing in Emergency Medicine at Vancouver General Hospital. He holds an undergraduate degree in engineering from Queen's University and a Master of Business Administration from Ivey Business School. He brings experience in project management, quality improvement, medical research and first hand healthcare knowledge to the Difinity team.
Ishan Aditya, MD
StrategyIshan is a medical student at the University of Toronto who completed his undergraduate studies in the Bachelor of Health Sciences (Honours) Program at McMaster University. He is a well-published researcher, brings extensive leadership experience, and is an internationally accomplished public speaker. He wants to apply his passion for comprehensive patient care through Difinity to develop accessible technology to create preventative health solutions.
Roh Amromanoh, BME, MEng
Product Development & Market EntryRoh holds a Biosystems Engineering undergraduate degree specializing in Biomedical Engineering, as well as a Master of Science in Mechanical Engineering from the University of Manitoba. He is currently a Master of Business Administration (MBA) student at the University of Manitoba and is passionate about start-ups and medical device innovation and management. He brings a combination of technical and business knowledge to the Difinity team.
Aidan McParland, MD, MSc
GrowthAidan is a resident physician specializing in Emergency Medicine at Vancouver General Hospital. He holds a master's degrees in Pain Biology at the University of New England and completed his medical degree at the University of Toronto. He brings experience in basic science, clinical trials, as well as academic and organizational leadership to the Difinity team
Our Partners
Frequently Asked Questions
Feel free to contact us by email if you couldn't find an answer to your question in the following list
When did you start your company?
Do you have an Equality, Diversity and Inclusion (EDI) statement?
What have you accomplished so far?
Since starting NeedSafe, we have submitted patents for IP protection and developed a working prototype.
NeedSwitch:
We have submitted patents in various jurisdictions and have developed an alpha prototype with functionality for testing.
What is your product roadmap?
We are aiming to have a fully functioning device to undergo testing and manufacturing by the end of Q4 2023. We aim to submit and meet FDA, EU, and Health Canada Regulations for our device by the end of Q4 2025.
NeedSwitch:
We are partnering with a global CDMO to further develop, test, and manufacture our device with the goal of undergoing verification & validation testing for FDA, EU, and Health Canada submission by Q1 2026
How can I invest with Difinity?
Our Features
StartUp Health & Health Transformers Feature
Difinity Solutions Introduces the First Modular, Multi-Dose Emergency Medication Delivery System
Read more
The Health Impact Investor Challenge Top 5 Ventures: Get to Know the Cohort
After the second Pitch Night of the 2022 Health Impact Investor Challenge, presented by the TELUS Pollinator Fund for Good, the venture cohort has been selected!
Read moreLet's Get In Touch
We look forward to hearing from you.